Description |
Request for Quotation (RFQ) RFQ_006_2023-2024 Services Required: Printing of Job Aids cum resource material for HIV treatment and adherence for patient education & counselling. RFQ number RFQ_006_2023-2024 Type of Procurement: Material Procurement Type of Contract: Purchase Order Term of Contract: 01st Aug.2023 – 30th Sep.2023 Contract Funding: Project Accelerate, Johns Hopkins University, USA, through YRGCARE, Chennai, India. Contracting number- 72038619CA00001 Submit Quotation to: rfp@yrgcare.org Date of Issue of RFQ: 03.07.2023 Date Questions from Supplier Due: 07.07.2023 Date YRGCARE responds to queries 10.07.2023 Date Quotation Due: 19.07.2023 Approximate Date Purchase Order/Contract Issued to Successful Bidder(s): 28.07.2023 Background on ACCELERATE and YRGCARE, Chennai, India Project ACCELERATE is awarded under the PEPFAR/USAID grant to Johns Hopkins University School of Medicine as prime recipient of the grant. ACCELERATE is implemented by its implementing partner- YRGCARE India to implement all site level activities and other sub-partners – Blue Lotus Advisories and The Fenway institute who provide expertise on digital interventions and sexual minorities and PrEP respectively The overarching goal of ACCELERATE is to design, implement and evaluate sustainable novel models of HIV testing and care that support the Indian National Strategic Plan (NSP) for HIV/AIDS and STI 2017-24 aimed at improving access to HIV prevention and treatment services, and social protection schemes among key populations and their families in India. The ACCELERATE program aims to build upon US government investment in India by providing technical assistance (TA) to National, State, and District HIV/AIDS programs to deliver comprehensive HIV prevention, testing and treatment services to vulnerable populations including key populations (KP), their children and partners. While the overall focus of the program is all vulnerable populations, we will focus primarily on four KP groups, including female sex workers (FSW), men who have sex with men (MSM), transgender persons (TG), and people who inject drugs (PWID) as there is a disproportionate burden of HIV in these key populations and an unmet need for services. We will primarily focus our field-level activities in ten high burden districts in the states of Maharashtra (Mumbai, Thane, Pune), Andhra Pradesh (Guntur, Krishna and East Godavari), Manipur (Imphal East and Imphal West), Mizoram (Aizawl) and Nagaland (Dimapur); while providing TA at the national, state, and district levels. Our core activities include innovative prevention and testing strategies like PrEP, HIVST, index testing, peer navigation and improving treatment and retention through integrated care models, community- based models, private sector engagement etc. YRGCARE, established in 1993, offers comprehensive HIV care continuum to those at risk and or with HIV. YRGCARE is a pioneering Institution involved in implementation research, program delivery and basic laboratory sciences. YRGCARE is an implementing partner for Johns Hopkins University, USA, for the Project ACCELERATE, funded by USAID, Government of USA. 1. Purpose of this RFQ, Scope of work and deliverables: Overview The purpose of this RFQ is to obtain competitive Quotations from qualified proposers to print NACP approved treatment job aids and related resource material for adherence and treatment literacy in alignment with national guidelines and overarching goals of 95-95-05. The overall objective is to strengthen the HIV AIDS epidemic control response, through capacity building & understanding of facility level staff on different aspects of HIV treatment and patient adherence through innovative approaches like job aids, ready reckoners posters and related resource material. Objectives: To assist ARTC staff during different stages of treatment counselling, as a ready reckoner as per the needs of the HIV patient To assist community outreach staff for patient counselling and education on different aspects of HIV treatment, help them overcome the information gap so as to ensure uninterrupted treatment on ART & TB/other OIs. For detailed information, please check the complete version of the advert attached below
|